The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers

Journal of Clinical Pharmacology

Volumn 36, Issue 7, 1996, Pages 647-653

  Melia, Angela T ^a   Koss Twardy, Susan G ^a   Zhi, Jianguo ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; RETINOL; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; FAT INTAKE; HUMAN; INTESTINE ABSORPTION; LIPID ABSORPTION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 0029784311     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04230.x     Document Type: Article

References (19)

1. Hadváry P, Lengsfeld H, Wolfer H: Inhibition of pancreatic lipases in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J 1988;256:357-361.
2. Borgström B: Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim Biophys Acta 1988;962:308-316.
3. Fernandez E, Borgström B: Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat. Biochim Biophys Acta 1989;1001:249-255.
4. Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH: Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994;56:82-85.
5. Johnson EJ, Krasinski SD, Howard LJ, Alger SA, Dutta SK, Russell RM: Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am J Clin Nutr 1992;55: 857-864.
6. Dimitrov NV, Meyer C, Gilliland D, Ruppenthal M, Chenoweth W, Malone W: Plasma tocopherol concentrations in response to supplemental vitamin E. Am J Clin Nutr 1991;53:723-729.
7. Drent ML, van der Veen EA: Lipase inhibition: a novel concept in the treatment of obesity. Int J Obesity 1993;17:241-244.
8. Tonstad D, Pometta D, Erkelens DW, Ose L, Moccetti T, Schouten JA, et al: The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidemia. Eur J Clin Pharmacol 1994;46:405-410.
9. Drent ML, Larsson I, William-Olsson T, Quaade F, Czubayko F, von Bergmann K, et al: Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obesity 1995;19:221-226.
10. Fernández E, Borgström B: Intestinal absorption of retinol and retinyl palmitate in the rat: effects of tetrahydrolipstatin. Lipids 1990;25:549-552.
11. Reitsma JB, Cabezas MC, de Bruin TWA, Erkelens DW: Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor. Metabolism 1994;43:293-298.
12. Zhi J, Melia AT, Koss-Twardy SG, Arora S, Patel IH: The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of β-carotene in healthy volunteers. J Clin Pharmacol 1996;36:152-159..
13. Marzo A, Rescigno A: Pharmacokinetics of endogenous substances: some problems and some solutions. Eur J Drug Metab Pharmacokinet 1993;18:77-88.
14. Grizzle JE: The two-period change-over design and its use in clinical trials. Biometrics 1965;21:467-480.
15. Grizzle JE: Corrections to the two-period change-over design and its use in clinical trials (letter). Biometrics 1974;30:727.
16. Baker H, Frank O, DeAngelis B, Feingold S: Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int 1980;21:531-536.
17. Traber MG, Burton GW, Ingold KU, Kayden HJ: RRR- and SRR-α-tocopherols are secreted without discrimination in human chylomicrons, but RRR-α-tocopherol is preferentially secreted in very low density lipoproteins. J Lipid Res 1990;31:675-685.
18. Johnson EJ, Krasinski SD, Russell RM: Sex differences in post-absorptive plasma vitamin A transport. Am J Clin Nutr 1992;56: 911-916.
19. Lombardo D, Guy O: Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. II. Action on cholesterol esters and lipid-soluble vitamin esters. Biochim Biophys Acta 1980;611:147-155.